Alimta Value Revisited: ASCO Raises Score In Framework Update
This article was originally published in The Pink Sheet Daily
Executive Summary
Underscoring the importance of context in understanding drug value scores, ASCO re-evaluates Lilly’s Alimta in consultation with the manufacturer and finds a higher score than it did originally.